A Day To Honour Dr. Daniel Sitar: Fellowship of the Society of Pharmacology and Therapeutics

dr daniel sitar wide

Today is a day to honour Dr Daniel Sitar: Fellowship Canadian Society of Pharmacology and Therapeutics

dr daniel sitar

Daniel Sitar

BScPharm, MSc, PhD, FGSA,FCP, Professor Emeritus, Rady Faculty of Health Sciences – College of Medicine (Departments of Internal Medicine, Pharmacology and Therapeutics, Pediatrics and Child Health), College of Pharmacy, and Centre on Aging, University of

Dr. Sitar completed his university degrees at the University of Manitoba. Subsequently, he was an MRC Postdoctoral Fellow in the Department of Pharmacology, University of Minnesota. Dr. Sitar then accepted academic positions at McGill University in 1973 in the Division of Experimental Medicine (Clinical Pharmacology Section), and in the Department of Pharmacology and Therapeutics, where he was appointed a Monat Scholar. 

In 1978, Dr. Sitar was recruited back to the University of Manitoba to the Department of Internal Medicine (Clinical Pharmacology) and the Department of Pharmacology and Therapeutics, where he participated in the development of the first Geriatric Clinical Pharmacology Research Program in Canada. 

Dr. Sitar served as Head of the Department of Pharmacology and Therapeutics from 1999 until 2008. His research area can broadly be described as drug disposition and effects at extremes of age, and encompasses both basic and clinical studies. From 1989-90 he was appointed Rosenstadt Professor at the University of Toronto in the Faculty of Pharmacy. 

Dr. Sitar has served on many research grant and advisory panels in various capacities, both in Canada and in the USA. He has served on several Editorial Boards of scientific research journals, including terms as Associate Editor and then Editor in Chief of the Journal of Clinical Pharmacology.

Dr. Sitar’s research contributions have been recognized by a number of awards in Canada, including the Piafsky Young investigator Award, and the Senior Investigator Award from the Canadian Society for Clinical Pharmacology. 

He is also a recipient of the Senior Scientist Award from the Pharmacological Society of Canada. In the USA, his research has been recognized by Fellowship awards from the Gerontological Society of America and the American College of Clinical Pharmacology.

Share this post:

Sign up for the latest Biomark news

No paperwork, no hassle. We keep things digital, easy and regular.

*Zero Spam Policy. You will need to confirm your email address to receive our news to your inbox.

BioMark Diagnostics Inc.
FSE: 20B

Related articles ...

© 2024 BioMark Diagnostics Inc. All Rights Reserved. BioMark’s mission is to provide universal access to a new paradigm in cancer diagnostics using metabolomics.